Form 4: Astrana Health Director John Chiang Reports Acquisition and Disposal of Common Stock

Director John Chiang reports transactions involving Astrana Health, Inc. common stock, including the acquisition of restricted shares and adjustments to beneficial ownership.

Summary

• On August 13, 2024, John Chiang, a director of Astrana Health, Inc. (ASTH), reported acquiring 3,564 shares of common stock.
• These shares were restricted shares granted under the company's 2024 Equity Incentive Plan and will vest on the earlier of August 13, 2025, or the date of the company's 2025 annual meeting of stockholders.
• Chiang also reported a disposal of shares.
• Following these transactions, Chiang beneficially owns 8,414 shares of common stock, including 4,750 shares of restricted stock vesting on December 9, 2024, and 3,564 shares vesting later.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The acquisition of restricted shares indicates confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted shares provides a timeline for potential future equity ownership changes.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders.

Key Dates